BOSTON, Mass., Sept. 4, 2025 /PRNewswire/ — Glytec, the leading provider of an AI-powered technology platform for diabetes and related conditions for hospitals and health systems, today announced that CIO Views has recognized Glytec’s impact on safer diabetes care and named CEO Patrick Cua among “The 10 Most Innovative CEOs Making a Difference in 2025.”
This annual list celebrates visionary leaders who are redefining their industries, driving digital transformation, and making lasting impacts on the people they serve.
The recognition reflects progress toward safer, more effective, and personalized diabetes management powered by Glytec’s FDA-cleared, EHR-integrated Glucommander™ platform. Glucommander has been shown to reduce severe hypoglycemia by up to 99.8% and shorten hospital length of stay by over 3 days, directly addressing one of the most pressing patient safety challenges in healthcare. In partnership with hospital technology leaders, Glytec leverages AI, automating workflows, reducing manual processes, and better orchestrating hospital hardware and software. Glytec’s zero-trust architecture, cloud-based interoperability, and return-on-investment (ROI) within the first 3 months help health systems realize value quickly, with over 400 hospital clients, over 100 patents, and validation by over 100 publications.
“We are deeply honored to be recognized among such an inspiring group of leaders,” said Patrick Cua, CEO of Glytec. “This acknowledgment reflects the hard work of our entire team and the dedication of clinicians and care teams who use Glytec software every day. Our focus is making it easier for hospitals and clinicians to deliver measurable improvements in diabetes care for the people they serve. We remain dedicated to innovation, expanding our ecosystem of partners, and making it easy for hospitals, clinicians, and patients to achieve measurable improvement in diabetes care.”
With more than 30 years of leadership experience in healthcare, Cua champions Glytec’s mission to optimize diabetes management across the continuum of care. That mission-first focus has helped position Glytec as a trusted partner for health systems nationwide.
The CIO Views profile highlights Glytec’s role in shaping the future of diabetes care and the leadership approach behind it.
About Glytec
Glytec’s industry-leading, AI-driven technology platform, trusted by over 400 hospitals, empowers collaborative diabetes management and insulin dosing, improving patient outcomes, reducing hospital length of stay and readmissions, and optimizing clinical workflows. Its flagship solution, Glucommander®—the first-ever FDA-cleared cloud-based insulin management software, integrates seamlessly with EMRs, providing advanced clinical decision support, workflow alerts, patient monitoring, and comprehensive analytics. Supported by industry awards and over 100 patents and 100 peer-reviewed publications, Glytec is dedicated to improving care from the hospital to the home for patients, providers, and payers. For more information, visit www.glytec.com or follow Glytec on LinkedIn.
Media Contact:
Glytec Public Relations
glytecpr@glytec.com
SOURCE Glytec, LLC
Franklin, Tennessee--(Newsfile Corp. - December 23, 2025) - From global stages and scientific breakthroughs to…
MILFORD, Mass., Dec. 23, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.,…
Five teams won CES Innovation Awards, including one Best of Innovation Award and three double…
CAMBRIDGE, Mass., Dec. 23, 2025 /PRNewswire/ -- Next Gen Diagnostics (NGD) today announced that January…
The Estate of Neil Mellen Helps Build Destination for Advanced Cancer Care in ConnecticutBRIDGEPORT, Conn., Dec.…
New data from Health Union's survey of over 6,000 patients across 49 chronic conditions shows…